Cargando…
A retrospective study on the incidence, management and risk factors of skin rash in patients with advanced prostate cancer in Japan
BACKGROUND: Worldwide, prostate cancer (PC) is the second most diagnosed cancer and the fifth leading cause of cancer death in men. Hormonal therapies, commonly used for PC, are associated with a range of treatment-emergent adverse events (TEAEs). The population from Japan seems to be at higher risk...
Autores principales: | De Moor, Raf, Koroki, Yosuke, Wu, David Bin-Chia, Yu, Dae Young, Tohyama, Mikiko, Ohyama, Chikara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148545/ https://www.ncbi.nlm.nih.gov/pubmed/37118710 http://dx.doi.org/10.1186/s12894-023-01246-1 |
Ejemplares similares
-
Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
por: Uemura, Hiroji, et al.
Publicado: (2020) -
Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
por: Uemura, Hiroji, et al.
Publicado: (2020) -
Incidence of Skin Rash in the New H7N9 Influenza
por: Wiwanitkit, Somsri, et al.
Publicado: (2014) -
Apalutamide‐associated skin rash in patients with prostate cancer: Histological evaluation by skin biopsy
por: Tohi, Yoichiro, et al.
Publicado: (2021) -
Risperidone-induced skin rash
por: Janardhana, Priya, et al.
Publicado: (2016)